Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 275 No 7365 p273
3 September 2005

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Regulatory review should consider fitness for purpose

Andrew Foster

Andrew Foster has been told that too rigid regulation may hinder patient care

Consideration should be given to the overall fitness for purpose of the current regulatory framework for the non-medical health professions, the Royal Pharmaceutical Society has said.

Responding to a call for ideas from the Department of Health director of workforce, Andrew Foster, the Society says that regulation of the professions should not be considered in isolation, but in the context of health care regulation as a whole and what that is intended to achieve. Mr Foster is conducting a review of non-medical health regulation that parallels the chief medical officer’s review of the General Medical Council (PJ, 19 March, p323).

The Society’s response argues that the best system of regulation comprises a group of specialist regulators acting under the overall supervision of an oversight regulator. It suggests that the pharmacy profession would be particularly badly affected if the Society’s current regulatory roles were to be moved elsewhere because there would be no secure source of funding for the Society’s remaining professional roles, such as overseeing education and professional standards.

It suggests that the review should consider whether the focus of regulation should be on individual practitioners or the larger units within which they work. This is because the current professional registers arose from an era when health care was a smaller industry and was differently organised. Most professionals now work in teams, rather than alone, and are employees. Pharmacy is noted to be an exception to the rule, with 54 per cent of community pharmacists being either community pharmacy proprietors or self-employed locums. But the Society points out that only a minority offer professional services direct to patients or the public without some form of oversight by an intermediary, such as an NHS primary care organisation.

The response calls into doubt the role of individual professions and regulators in drawing up ethical codes for health professionals.

“ Behaviour and attitudes should be common to all health care professionals and set out in a common ethical code drawn up by the Council for Healthcare Regulatory Excellence and patient groups and widely consulted on,” it says.

Commenting on the regulation of new and extended professional roles, the Society warns Mr Foster that service development and innovation could be hindered if regulation is too rigid.

“If practice and specialisation are tied down in legislation and regulations, there are huge barriers to change, its states. “This may prevent improvements to patient care and workforce development, and that acts against the public interest. Protocols and guidelines can be updated more easily and allow for more flexibility.”

The full response is available on the Society’s website as a PDF file (200K).

Back to Top


©The Pharmaceutical Journal